Literature DB >> 12433601

Treatment of the axilla by tangential breast radiotherapy in women with invasive breast cancer.

Maureen A Chung1, Thomas DiPetrillo, Sophie Hernandez, Gabriela Masko, David Wazer, Blake Cady.   

Abstract

BACKGROUND: The objective of this study was to determine if standard tangential breast radiation covered the sentinel lymph node in women with invasive breast cancer.
METHODS: Women with invasive breast cancer treated by lumpectomy, radiotherapy and sentinel node biopsy at our institution were included in this study if the sentinel lymph node site had been marked with a clip. Plain films were used to determine if the clip fell within the tangential fields.
RESULTS: Between April 1999 and May 2001, 36 women with invasive breast cancer treated by lumpectomy, sentinel lymph node biopsy and breast radiation were identified. Median age was 56 years (range 34 to 80) with a median tumor size of 1.1 cm (range 0.3 to 2.9 cm). The clip marking the sentinel lymph node fell within the tangential fields in 34 of 36 (94%) of the patients. The radiation dose to the clip area was greater than 4,400 cGy in 50% of those calculated by three-dimensional techniques.
CONCLUSIONS: The sentinel lymph node is located within classic tangential fields in the overwhelming majority of women with invasive breast cancer. The extent of the radiation fields, and ultimately the final dose, may need to be modified if the intent is for prophylactic treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12433601     DOI: 10.1016/s0002-9610(02)01013-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

Review 1.  The Adventure of Axillary Treatment in Early Stage Breast Cancer.

Authors:  Bekir Kuru
Journal:  Eur J Breast Health       Date:  2020-01-01

2.  Omitting SLNB in Breast Cancer: Is a Nomogram the Answer?

Authors:  A M Moorman; E J Th Rutgers; E A Kouwenhoven
Journal:  Ann Surg Oncol       Date:  2021-11-05       Impact factor: 5.344

3.  Axillary lymph node dose with tangential whole breast radiation in the prone versus supine position: a dosimetric study.

Authors:  Kara Lynne Leonard; David Solomon; Jaroslaw T Hepel; Jessica R Hiatt; David E Wazer; Thomas A DiPetrillo
Journal:  Radiat Oncol       Date:  2012-05-18       Impact factor: 3.481

Review 4.  Axillary recurrence after a tumor-positive sentinel lymph node biopsy without axillary treatment: a review of the literature.

Authors:  Claire M T P Francissen; Pim J M Dings; Thijs van Dalen; Luc J A Strobbe; Hanneke W M van Laarhoven; Johannes H W de Wilt
Journal:  Ann Surg Oncol       Date:  2012-08-14       Impact factor: 5.344

5.  Three-Dimensional Breast Radiotherapy and the Elective Radiation Dose at the Sentinel Lymph Node Site in Breast Cancer.

Authors:  Lori M van Roozendaal; Robert-Jan Schipper; Leonie H M Smit; Boudewijn T Brans; Regina G H Beets-Tan; Marc B I Lobbes; Liesbeth J Boersma; Marjolein L Smidt
Journal:  Ann Surg Oncol       Date:  2015-02-24       Impact factor: 5.344

6.  Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08).

Authors:  L M van Roozendaal; M L G Vane; T van Dalen; J A van der Hage; L J A Strobbe; L J Boersma; S C Linn; M B I Lobbes; P M P Poortmans; V C G Tjan-Heijnen; K K B T Van de Vijver; J de Vries; A H Westenberg; A G H Kessels; J H W de Wilt; M L Smidt
Journal:  BMC Cancer       Date:  2017-07-01       Impact factor: 4.430

7.  Evaluation of Sentinel Lymph Node Dose Distribution in 3D Conformal Radiotherapy Techniques in 67 pN0 Breast Cancer Patients.

Authors:  Gerlo Witucki; Nikolaus Degregorio; Andreas Rempen; Lukas Schwentner; Dirk Bottke; Wolfgang Janni; Florian Ebner
Journal:  Int J Breast Cancer       Date:  2015-06-28

8.  Quantifying the Mitigating Effects of Whole-Breast Radiotherapy and Systemic Treatments on Regional Recurrence Incidence Among Breast Cancer Patients.

Authors:  Julia E C van Steenhoven; Anne Kuijer; Marissa C van Maaren; Marleen Roos; Sjoerd G Elias; Paul J van Diest; Sabine Siesling; Marjolein L Smidt; Liesbeth J Boersma; Thijs van Dalen
Journal:  Ann Surg Oncol       Date:  2020-03-20       Impact factor: 5.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.